Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Syndax Pharmaceuticals, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 14||$ 17.49|
|Low||$ 13.6601||$ 10.60|
The current last sale of $13.69 is 29.15% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with our initial focus on tumors that have shown sensitivity to immunotherapy, including lung cancer, melanoma, ovarian cancer and triple negative breast cancer, or TNBC. Entinostat is our oral, small molecule drug candidate that has direct effects on both cancer cells and immune regulatory cells, potentially enhancing the body's immune response to tumors. The favorable safety profile of entinostat has been demonstrated in clinical trials in more than 900 cancer patients. ... More ...
Where does SNDX fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$999|
|Quarterly EPS Est:||-0.47|